Meridian Bioscience (NASDAQ: VIVO)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Meridian Bioscience (NASDAQ: VIVO) through any online brokerage.
The latest price target for Meridian Bioscience (NASDAQ: VIVO) was reported by HC Wainwright & Co. on Monday, February 7, 2022. The analyst firm set a price target for 30.00 expecting VIVO to fall to within 12 months (a possible -2.91% downside). 3 analyst firms have reported ratings in the last year.
The stock price for Meridian Bioscience (NASDAQ: VIVO) is $30.9 last updated July 1, 2022, 8:00 PM UTC.
A quarterly cash dividend of $0.13 per share of Class A Common Stock. The quarterly cash dividend was payable on February 14, 2019 to stockholders of record on February 1, 2019.
Meridian Bioscience’s Q3 earnings are confirmed for Friday, August 5, 2022.
There is no upcoming split for Meridian Bioscience.
Meridian Bioscience is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.